179 related articles for article (PubMed ID: 36543879)
1. Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.
Braunstein EM; Imada E; Pasca S; Wang S; Chen H; Alba C; Hupalo DN; Wilkerson M; Dalgard CL; Ghannam J; Liu Y; Marchionni L; Moliterno A; Hourigan CS; Gondek LP
Leukemia; 2023 Mar; 37(3):627-635. PubMed ID: 36543879
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
3. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Hinds DA; Barnholt KE; Mesa RA; Kiefer AK; Do CB; Eriksson N; Mountain JL; Francke U; Tung JY; Nguyen HM; Zhang H; Gojenola L; Zehnder JL; Gotlib J
Blood; 2016 Aug; 128(8):1121-8. PubMed ID: 27365426
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E; Cazzola M
Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
[TBL] [Abstract][Full Text] [Related]
5. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
6. Familial MPN Predisposition.
Tashi T; Swierczek S; Prchal JT
Curr Hematol Malig Rep; 2017 Oct; 12(5):442-447. PubMed ID: 29027642
[TBL] [Abstract][Full Text] [Related]
7. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
8. Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms.
Yin L; Xie S; Chen Y; Li W; Jiang X; Li H; Li J; Wu Z; Xiao X; Zhang G; Cheng Z; Peng H
Ann Hematol; 2021 Sep; 100(9):2229-2240. PubMed ID: 34228147
[TBL] [Abstract][Full Text] [Related]
9. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.
Jäger R; Harutyunyan AS; Rumi E; Pietra D; Berg T; Olcaydu D; Houlston RS; Cazzola M; Kralovics R
Am J Hematol; 2014 Dec; 89(12):1107-10. PubMed ID: 25196853
[TBL] [Abstract][Full Text] [Related]
10. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
[TBL] [Abstract][Full Text] [Related]
11. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
[TBL] [Abstract][Full Text] [Related]
12. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
Prodosmo A; Buffone A; Mattioni M; Barnabei A; Persichetti A; De Leo A; Appetecchia M; Nicolussi A; Coppa A; Sciacchitano S; Giordano C; Pinnarò P; Sanguineti G; Strigari L; Alessandrini G; Facciolo F; Cosimelli M; Grazi GL; Corrado G; Vizza E; Giannini G; Soddu S
J Exp Clin Cancer Res; 2016 Sep; 35(1):135. PubMed ID: 27599564
[TBL] [Abstract][Full Text] [Related]
13. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
14. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Graffeo R; Rana HQ; Conforti F; Bonanni B; Cardoso MJ; Paluch-Shimon S; Pagani O; Goldhirsch A; Partridge AH; Lambertini M; Garber JE
Breast; 2022 Oct; 65():32-40. PubMed ID: 35772246
[TBL] [Abstract][Full Text] [Related]
15. Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Bao EL; Nandakumar SK; Liao X; Bick AG; Karjalainen J; Tabaka M; Gan OI; Havulinna AS; Kiiskinen TTJ; Lareau CA; de Lapuente Portilla AL; Li B; Emdin C; Codd V; Nelson CP; Walker CJ; Churchhouse C; de la Chapelle A; Klein DE; Nilsson B; Wilson PWF; Cho K; Pyarajan S; Gaziano JM; Samani NJ; ; ; Regev A; Palotie A; Neale BM; Dick JE; Natarajan P; O'Donnell CJ; Daly MJ; Milyavsky M; Kathiresan S; Sankaran VG
Nature; 2020 Oct; 586(7831):769-775. PubMed ID: 33057200
[TBL] [Abstract][Full Text] [Related]
16. Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.
Dalmasso B; Pastorino L; Nathan V; Shah NN; Palmer JM; Howlie M; Johansson PA; Freedman ND; Carter BD; Beane-Freeman L; Hicks B; Molven A; Helgadottir H; Sankar A; Tsao H; Stratigos AJ; Helsing P; Van Doorn R; Gruis NA; Visser M; Wadt KAW; Mann G; Holland EA; Nagore E; Potrony M; Puig S; Menin C; Peris K; Fargnoli MC; Calista D; Soufir N; Harland M; Bishop T; Kanetsky PA; Elder DE; Andreotti V; Vanni I; Bruno W; Höiom V; Tucker MA; Yang XR; Andresen PA; Adams DJ; Landi MT; Hayward NK; Goldstein AM; Ghiorzo P; ;
Genet Med; 2021 Nov; 23(11):2087-2095. PubMed ID: 34262154
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
[TBL] [Abstract][Full Text] [Related]
18. Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms.
Elbracht M; Meyer R; Kricheldorf K; Gezer D; Eggermann T; Betz B; Kurth I; Teichmann LL; Brümmendorf TH; Germing U; Isfort S; Koschmieder S
Blood Adv; 2021 Sep; 5(17):3373-3376. PubMed ID: 34477817
[TBL] [Abstract][Full Text] [Related]
19. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
[TBL] [Abstract][Full Text] [Related]
20. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]